Halozyme Therapeutics Inc (HALO) — Free Cash Flow Generation Index
Halozyme Therapeutics Inc (HALO) has a Free Cash Flow Generation Index of 0.98x as of September 2025. Free cash flow of $175.57 Million represents 1% of operating cash flow ($178.60 Million). See Halozyme Therapeutics Inc (HALO) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Halozyme Therapeutics Inc Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Halozyme Therapeutics Inc across 7 annual periods. Explore HALO cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Halozyme Therapeutics Inc (2006–2024)
Year-by-year Free Cash Flow Generation Index for Halozyme Therapeutics Inc. For the full company profile including market capitalisation, see Halozyme Therapeutics Inc market cap and net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.98x | $468.37 Million | $479.06 Million | $10.70 Million | ▲ +1.8% |
| 2023 | 0.96x | $373.28 Million | $388.57 Million | $15.29 Million | ▼ -2.0% |
| 2022 | 0.98x | $235.30 Million | $240.11 Million | $4.81 Million | ▼ -1.5% |
| 2021 | 1.00x | $297.98 Million | $299.44 Million | $1.46 Million | ▲ +4.2% |
| 2020 | 0.95x | $52.95 Million | $55.45 Million | $2.50 Million | ▼ -3.5% |
| 2017 | 0.99x | $132.70 Million | $134.05 Million | $1.35 Million | ▲ +4.4% |
| 2006 | 0.95x | $6.71 Million | $7.08 Million | $364.80K | — |